NOK 223.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.03 Billion | 1.24 Billion | 1.68 Billion | 1.37 Billion | 1.49 Billion | 1.58 Billion |
Net Income | -1.62 Billion | 3.13 Billion | 4.76 Billion | 338 Million | 2.33 Billion | 2.88 Billion |
Depreciation & Amortization | 17 Million | 26 Million | 32 Million | 35 Million | 23 Million | 20 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 206 Million | -608 Million | -147 Million | -57 Million | -55 Million | 42 Million |
Other non-cash items | 3.43 Billion | -1.3 Billion | -2.96 Billion | 1.05 Billion | -807 Million | -1.35 Billion |
Investing Cash Flow | -1.97 Billion | -537 Million | -492 Million | -410 Million | -573 Million | -1.38 Billion |
Investments in PPE | -708 Million | -706 Million | -14 Million | -680 Million | -672 Million | -1.16 Billion |
Acquisitions | -1.22 Billion | -72 Million | 366 Million | -33 Million | -55 Million | -22 Million |
Investment purchases | -48 Million | 706 Million | -859 Million | 680 Million | 672 Million | -1.38 Billion |
Sales/Maturities of investments | 48 Million | 240 Million | 14 Million | 304 Million | 155 Million | - |
Other Investing Activities | -48 Million | -705 Million | 1 Million | -681 Million | -673 Million | -203 Million |
Financing Cash Flow | -92 Million | -900 Million | -1.22 Billion | -868 Million | -847 Million | -262 Million |
Debt repayment | -588 Million | -9.2 Billion | -15.24 Billion | -11.09 Billion | -19.07 Billion | -18.62 Billion |
Dividends payments | -660 Million | -691 Million | -518 Million | -13 Million | -456 Million | -233 Million |
Common Stock Repurchased | - | -398 Million | - | - | -341 Million | - |
Common Stock Issuance | - | - | - | - | 19.04 Billion | - |
Other Financing Activities | -12 Million | 9.39 Billion | 14.53 Billion | 10.24 Billion | 1 Million | 18.61 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 199 Million | - | - | - | -55 Million | 42 Million |
Cash at beginning of period | 254 Million | 448 Million | 484 Million | 386 Million | 305 Million | 366 Million |
Cash at end of period | 226 Million | 254 Million | 448 Million | 484 Million | 386 Million | 305 Million |
Capital Expenditure | -708 Million | -706 Million | -14 Million | -680 Million | -672 Million | -1.16 Billion |
Effect of forex changes on cash | 9 Million | - | -2 Million | 4 Million | 2 Million | - |
Net cash flow / Change in cash | -28 Million | -194 Million | -36 Million | 98 Million | 81 Million | -61 Million |
Free Cash Flow | 1.32 Billion | 537 Million | 1.67 Billion | 693 Million | 825 Million | 426 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 219 Million | 527 Million | -1.38 Billion | -1.62 Billion | 531 Million | 584 Million |
Depreciation & Amortization | 3 Million | 3 Million | 4 Million | 17 Million | 3 Million | 4 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -250 Million | 222 Million | -466 Million | 206 Million | 276 Million | 116 Million |
Other non-cash items | 127 Million | 331 Million | 1.86 Billion | 3.43 Billion | -3 Million | -139 Million |
Investing Cash Flow | -237 Million | -139 Million | 160 Million | -1.97 Billion | -191 Million | -559 Million |
Investments in PPE | -203 Million | -112 Million | -134 Million | -708 Million | -125 Million | -265 Million |
Acquisitions | -23 Million | -17 Million | - | -1.22 Billion | - | - |
Investment purchases | - | - | 295 Million | -48 Million | -66 Million | - |
Sales/Maturities of investments | - | - | - | 48 Million | - | - |
Other Investing Activities | -11 Million | -10 Million | -1 Million | -48 Million | -66 Million | -294 Million |
Financing Cash Flow | 60 Million | -479 Million | -168 Million | -92 Million | -569 Million | -104 Million |
Debt repayment | -776 Million | -477 Million | -166 Million | -588 Million | -1.85 Billion | -878 Million |
Dividends payments | -714 Million | - | - | -660 Million | - | -660 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2 Million | - | -2 Million | -12 Million | 1.28 Billion | 1.44 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -250 Million | - | - | - | - | - |
Cash at beginning of period | 245 Million | 226 Million | 215 Million | 254 Million | 161 Million | 259 Million |
Cash at end of period | 161 Million | 245 Million | 226 Million | 226 Million | 215 Million | 161 Million |
Capital Expenditure | -203 Million | -112 Million | -134 Million | -708 Million | -125 Million | -265 Million |
Effect of forex changes on cash | - | - | -2 Million | 9 Million | 7 Million | - |
Net cash flow / Change in cash | -84 Million | 19 Million | 11 Million | -28 Million | 54 Million | -98 Million |
Free Cash Flow | -110 Million | 525 Million | -113 Million | 1.32 Billion | 682 Million | 300 Million |
NWSGY
MING
002852
GAN
APCOTEXIND
HMX